These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25997320)

  • 21. Subcutaneous versus intravenous granulocyte colony stimulating factor for the treatment of neutropenia in hospitalized hemato-oncological patients: randomized controlled trial.
    Paul M; Ram R; Kugler E; Farbman L; Peck A; Leibovici L; Lahav M; Yeshurun M; Shpilberg O; Herscovici C; Wolach O; Itchaki G; Bar-Natan M; Vidal L; Gafter-Gvili A; Raanani P
    Am J Hematol; 2014 Mar; 89(3):243-8. PubMed ID: 24178750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin.
    Pagani M; Bonadonna P; Senna GE; Antico A
    Int Arch Allergy Immunol; 2008; 145(1):54-7. PubMed ID: 17703101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing Allergic Reactions to Gadolinium-Based Contrast Agents.
    Heshmatzadeh Behzadi A; Prince MR
    Top Magn Reson Imaging; 2016 Dec; 25(6):275-279. PubMed ID: 27748715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desensitization to chemotherapeutic agents.
    Lieberman P; Castells M
    J Allergy Clin Immunol Pract; 2014; 2(1):116-7. PubMed ID: 24565784
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost benefit and clinical efficacy of low-dose granulocyte colony-stimulating factor after standard chemotherapy in patients with non-Hodgkin's lymphoma.
    Hashino S; Morioka M; Irie T; Shiroshita N; Kawamura T; Suzuki S; Iwasaki H; Umehara S; Kakinoki Y; Kurosawa M; Kahata K; Izumiyama K; Kobayashi H; Onozawa M; Takahata M; Fujisawa F; Kondo T; Asaka M
    Int J Lab Hematol; 2008 Aug; 30(4):292-9. PubMed ID: 18665826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pustular eruption associated with granulocyte colony-stimulating factor treatment.
    Brumana MB; Russo I; Zambello R; Alaibac M
    G Ital Dermatol Venereol; 2018 Apr; 153(2):276-277. PubMed ID: 27845511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonallergic drug hypersensitivity reactions.
    Farnam K; Chang C; Teuber S; Gershwin ME
    Int Arch Allergy Immunol; 2012; 159(4):327-45. PubMed ID: 22832422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunologic desensitization].
    Valovirta E
    Duodecim; 1998; 114(17):1739-46. PubMed ID: 11717782
    [No Abstract]   [Full Text] [Related]  

  • 29. [Filgrastim in the treatment of severe neutropenia in a patient with bilobar pneumonia].
    Marcos Sánchez F; Juárez Ucelay F; Plaza Díaz R; Durán Pérez-Navarro A
    An Med Interna; 1995 Feb; 12(2):100-1. PubMed ID: 7538330
    [No Abstract]   [Full Text] [Related]  

  • 30. Contribution of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) use in current cancer treatment: review of clinical data.
    Gunzer K; Clarisse B; Lheureux S; Delcambre C; Joly F
    Expert Opin Biol Ther; 2010 Apr; 10(4):615-30. PubMed ID: 20218922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity.
    Limsuwan T; Castells MC
    Expert Opin Drug Saf; 2010 Jan; 9(1):39-53. PubMed ID: 20001753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor.
    Tulpule S; Shaw BE; Makoni P; Little AM; Madrigal JA; Goldman JM
    Bone Marrow Transplant; 2009 Jul; 44(2):129-30. PubMed ID: 19151798
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule.
    Meyer L; Zuberbier T; Worm M; Oettle H; Riess H
    J Clin Oncol; 2002 Feb; 20(4):1146-7. PubMed ID: 11844841
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful desensitization to docetaxel after severe hypersensitivity reactions in two patients.
    Reeves DJ; Callahan MJ; Sutton GP
    Am J Health Syst Pharm; 2012 Mar; 69(6):499-503. PubMed ID: 22382481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
    Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
    Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of hypersensitivity reactions occurring during anaesthesia. Choice of agents and anaesthetic techniques].
    Malinovsky JM; Lavaud F; Demoly P; Mertes PM; Plaud B
    Ann Fr Anesth Reanim; 2011 Mar; 30(3):305-11. PubMed ID: 21392930
    [No Abstract]   [Full Text] [Related]  

  • 37. [Desensitization in drug hypersensitivity].
    Piotrowicz-Wójcik K; Porebski G; Czarnobilska E
    Przegl Lek; 2013; 70(12):1008-10. PubMed ID: 24720117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Allergies--specific immunotherapy for rifampicin allergy].
    Pneumologie; 2007 Oct; 61(10):624. PubMed ID: 17922380
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hypersensitivity to platinum salts and taxanes: The value of skin tests and tolerance induction procedures].
    Brault F; Waton J; Poreaux C; Schmutz JL; Barbaud A
    Ann Dermatol Venereol; 2017 Nov; 144(11):685-695. PubMed ID: 28760501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid desensitization for hypersensitivity reactions to medications.
    Castells M
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):585-606. PubMed ID: 19563999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.